An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot Testosterone 50 mg, 75 mg, or 100 mg by Intended Users and QuickShot Summative Usability Study
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Testosterone enanthate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- Sponsors Antares Pharma
- 28 Nov 2016 Status changed from active, no longer recruiting to completed.
- 16 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.